ABOUT US

MEBO® is an emerging global brand of traditional medicine and consumer health products, with scientifically approved skin regenerative technology developed by the MEBO group of companies. We aim to bring the best natural healing solution for skin injury.

MEBO Malaysia (MEBO HEALTHCARE SDN. BHD. ) supply hospitals, medical centres, pharmacy wholesalers, pharmacies, health stores and health practitioners directly or through our distribution partners.

We offer educational programmes abroad for doctors and nurses in Moist Exposed Burn Ointment (MEBO) and Moist Exposed Burn Therapy (MEBT), along with national educational programmes for retailers and medical practitioners.   

MEBO Malaysia and the Mebo International Group, provide access to specialist medical doctors in the science of burns, ulcers and other topical skin wounds. 

Moist Exposed Burn Ointment, registered medicine in over 30 countries globally, is marketed as Mebo wound ointment in Malaysia and have entered into NPRA. Since 2010, MEBO Wound ointment has been distributed in Malaysian local pharmacies and laterally available in burn centres. 

MEBO ointment, used in over 20 thousand hospitals world-wide, has treated more than 20 million patients to date. Mebo's medical research is supported with over 3500 published clinical papers on Moist Exposed Burn Ointment.

Mebo's international head office is based in Los Angeles, California, U.S.A. The group holds more than 20 patents in the US, Canada, Europe, Japan and China for cell and organ regeneration.

Mebo's manufacturing sites include China and the United Arab Emirates. All facilities are certified with Good Manufacturing Practice certification (GMP).

The Mebo International Group's research focuses on the applications of stem cell and regenerative medicine, potentiating and stimulating stem cells in situ, directly repairing and regenerating skin tissue without the need for skin transplants. 

The company has received many international acknowledgements for research and success in burn wound therapy, including:

  • The Award of Achievement for Elite (UAE); 2000
  • The D'Honneur Exceptional, France; 1992
  • The States Outstanding Contributing Scientist of China; 1992
  • The American Burns Victim Society's Humanitarian Prize; 1993

More recently, in 2013, Professor Xu, founder of The Mebo International Group, was awarded The Golden Biatec Award, for his contribution to the wellbeing of the world population through his most recent US patent, 'Damaged Organ Regeneration'.